GLRA3 IDG ionchannel ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GLRA3 IDG ionchannel ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GLRA3 IDG ionchannel ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GLRA3 IDG ionchannel ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GLRA3 IDG ionchannel ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

septin 7 pseudogene 2

Gene

killer cell immunoglobulin like receptor, three Ig domains X1 (pseudogene)

Gene

HERC2 pseudogene 5

Gene

deleted in esophageal cancer 1

Gene

long intergenic non-protein coding RNA 2898

Gene

HERC2 pseudogene 8

Gene

myelodysplastic syndrome 2 translocation associated

Gene

protein FAM169B

Gene

YWHAQ pseudogene 5

Gene

TMPRSS11B N-terminal like (pseudogene)

  • Gene

    septin 7 pseudogene 2


  • Gene

    killer cell immunoglobulin like receptor, three Ig domains X1 (pseudogene)


  • Gene

    HERC2 pseudogene 5


  • Gene

    deleted in esophageal cancer 1


  • Gene

    long intergenic non-protein coding RNA 2898


  • Gene

    HERC2 pseudogene 8


  • Gene

    myelodysplastic syndrome 2 translocation associated



  • Gene

    YWHAQ pseudogene 5


  • Gene

    TMPRSS11B N-terminal like (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.